FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of Polyphor

Polyphor appoints Michael Altorfer as new CEO

19-Mar-2015 - Polyphor Ltd announced the appointment of Michael Altorfer as new CEO and successor of Jean-Pierre Obrecht as of March 31, 2015. Jean-Pierre Obrecht will continue to support the company in his role as a Member of the Board of Directors.Michael Altorfer joined Polyphor in 2001. He has served ...

appointments

Polyphor and Roche join effort to combat multidrug-resistant bacterial infections

06-Nov-2013 - Polyphor Ltd and Roche announced that they have entered into an exclusive worldwide license agreement to develop and commercialize Polyphor’s investigational macrocycle antibiotic, POL7080, for patients suffering from bacterial infections caused by Pseudomonas aeruginosa. Under the terms of the ...

antibiotics bacterial infections infectious diseases +1

Axxam and Polyphor Participate in a Research Partnership for the Treatment of Type-2 Diabetes Funded by the EU

29-Jul-2011 - Axxam Spa and Polyphor Ltd announced a joint discovery research project for the generation of GLP-1R modulators. The partnership will receive funding from the EU as part of the Eurostars Program aimed at supporting innovation within the European Union.The two companies will undertake a three-year ...

type 2 diabetes

Polyphor Ltd and Axxam SpA Announce Ion Channel Collaboration

13-Apr-2010 - Polyphor Ltd and Axxam SpA announced a joint discovery agreement with a synergistic combination of their discovery platforms. Under the terms of the collaboration the two companies will work together to discover and develop innovative drug candidates for selected therapeutic areas such as pain, ...

drug development inflammation ion channels +2